Results 121 to 130 of about 9,248 (241)

The aging paradox of Cushing's syndrome: Stress without clear senescence?

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 6, June 2026.
Abstract Cushing's syndrome (CS), characterized by chronic endogenous hypercortisolism and disruption of the normal circadian cortisol rhythm, represents a unique human model for investigating the interplay between stress endocrinology and biological aging.
Israel Nunes Silveira   +1 more
wiley   +1 more source

Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Chemotherapy and targeted drugs-induced senescent ovarian cancer cells that accumulate in peritoneal adipose tissue contribute significantly to chronic inflammation, disrupt homeostasis, and may fuel various aspects of cancer progression.
Lian Wang   +8 more
semanticscholar   +1 more source

Co‐pathologies and biological processes beyond amyloid‐beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies

open access: yesJournal of Internal Medicine, Volume 299, Issue 6, Page 694-710, June 2026.
Abstract Alzheimer's disease (AD) is neuropathologically defined by amyloid‐beta (Aβ) plaques and tau neurofibrillary tangles. However, co‐pathologies and other pathobiological processes are involved in the pathogenesis of AD, contributing to neurodegeneration and clinical symptoms.
Daniel Ferreira   +9 more
wiley   +1 more source

Senolytic combination of dasatinib and quercetin protects against diabetic kidney disease by activating autophagy to alleviate podocyte dedifferentiation via the Notch pathway

open access: yesInternational Journal of Molecular Medicine
The senolytics dasatinib and quercetin (DQ) alleviate age-related disorders. However, limited information is available regarding the effects of DQ on diabetic kidney disease (DKD).
Xinwang Zhu   +4 more
semanticscholar   +1 more source

Exploring Senolytic and Senomorphic Properties of Medicinal Plants for Anti-Aging Therapies

open access: yesInternational Journal of Molecular Sciences
Senolytic and senomorphic therapies have gained more and more attention in the last decade. This kind of therapy is based on the killing of cellular senescent cells without harming the “normal” cells. Aging is not a disease.
Monika Imb   +3 more
semanticscholar   +1 more source

The dual role of cellular senescence in human tumor progression and therapy

open access: yesMedComm
Cellular senescence, one of the hallmarks of cancer, is characterized by cell cycle arrest and the loss of most normal cellular functions while acquiring a hypersecretory, proinflammatory phenotype.
Liang Ma   +8 more
doaj   +1 more source

Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes

open access: yesClinical and Translational Medicine
Tumour cell senescence can be induced by various factors, including DNA damage, inflammatory signals, genetic toxins, ionising radiation and nutrient metabolism.
Jiaqiang Xiong   +8 more
doaj   +1 more source

Moving senolytics closer to the clinic in IPF

open access: yeseBioMedicine, 2023
Daniel Kramer   +2 more
openaire   +3 more sources

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy